Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer-Reference-Cited by-同舟云学术

Phosphorylation of the androgen receptor at Ser81 is co‐sustained by CDK1 and CDK9 and leads to AR‐mediated transactivation in prostate cancer

Published:2021-05-03 Issue: Volume: Page:
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:Mol Oncol

Author:

Gao XinTao¹,Liang Jiaqian²³,Wang LiYang²,Zhang Zhaoyang⁴,Yuan Penghui¹,Wang Jiaxin¹,Gao Yanfei⁵,Ma Fen²,Calagua Carla²,Ye Huihui⁶⁷,Voznesensky Olga²,Wang Shaogang¹,Wang Tao¹,Liu Jihong¹,Chen Shaoyong²^ORCID,Liu Xiaming¹

Affiliation:

1. Department of Urology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

2. Hematology‐Oncology Division Department of Medicine Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA

3. Wuhan No. 1 Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

4. Department of Biochemistry and Molecular Biology Institute of Basic Medical Sciences College of Basic Medicine Hubei University of Medicine Shiyan China

5. Department of Orthopaedic Surgery The Second Affiliated Hospital Chongqing Medical University China

6. Department of Pathology Beth Israel Deaconess Medical Center Harvard Medical School Boston MA USA

7. Department of Pathology University of California Los Angeles CA USA

Funder

U.S. Department of Defense

National Cancer Institute

Huazhong University of Science and Technology

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link